TO: Regulatory Information Service
PR Newswire
RE: Paragraph 3.1.4 of the Disclosure and Transparency Rules
The notification listed below was received under Paragraph 3.1.2 of the
Disclosure and Transparency Rules.
Diageo plc (the "Company") announces that it received notification today that
the following directors, as participants in the Diageo Dividend Reinvestment
Plan (the "Plan") received ordinary shares of 28 101/108 pence in the Company
("Ordinary Shares") in respect of the interim dividend paid on 10 April 2007 as
follows:
Name of Director Number of Ordinary Shares
Lord Blyth 1,661
NC Rose 4,221
JR Symonds* 61
The Ordinary Shares were purchased on 10 and 11 April 2007 (with a settlement
date of 16 April 2007) at an average price of £10.417.
As a result of the above transaction, these directors' interests in the
Company's Ordinary Shares (excluding options, awards under the Company's LTIPs
and interests as potential beneficiaries of the Company's employee benefit
trusts) have increased as follows:
Name of Director Number of Ordinary Shares
Lord Blyth 142,572
NC Rose 360,452
JR Symonds* 5,159
* In respect of shares held by spouse
16 April 2007
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.